モリモト サトシ
Morimoto Satoshi
森本 聡 所属 医学部 医学科(東京女子医科大学病院) 職種 准教授 |
|
論文種別 | 症例報告 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | A case report of interferon beta monotherapy for high hepatitis C viral load in dialysis patients. |
掲載誌名 | 正式名:Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 略 称:Ther Apher Dial ISSNコード:17449979/17449979 |
掲載区分 | 国外 |
巻・号・頁 | 11(4),pp.306-8 |
著者・共著者 | Nakajima Fumitaka, Fukii Masayoshi, Kitamura Testuya, Sakaida Aya, Sakaguchi Masahiro, Oka Hiroshi, Morimoto Satoshi, Masaki Hiroya, Yamahara Hideki, Shibahara Nobuhisa, Inoue Toru |
発行年月 | 2007/08 |
概要 | A 42-year-old male dialysis patient was infected with hepatitis C virus (HCV), and treated with interferon beta (IFN-beta) for a rapid increase in viral load. After dialysis three times a week, 3 million units of IFN-beta were intravenously infused for 1 h. The treatment was markedly effective, and the virus was eliminated in the sixth week. Therapy was continued for 24 weeks, and HCV negativity has been maintained for more than 6 months after the completion of administration. The blood IFN level slowly decreased immediately after administration. The mean trough level was 37 U/mL, and the half-life was 65 min. No adverse event requiring discontinuation of the treatment occurred, showing that IFN alone may safely eliminate the virus in dialysis patients with high hepatitis C viral load. Many dialysis patients are latently infected with HCV, and the infection affects the prognosis. Therefore, establishment of a therapeutic method is urgently needed. |
DOI | 10.1111/j.1744-9987.2007.00488.x |
PMID | 17661838 |